Herpes simplex virus seroprevalence among children, adolescents and adults in Greece

Int J STD AIDS 2008;19:272-278
doi:10.1258/ijsa.2007.007142
© 2008 Royal Society of Medicine Press

 

This Article

Figures Only

Full Text

Full Text (PDF)


Alert me when this article is cited

Alert me if a correction is posted
Services

Email this article to a friend

Similar articles in this journal


Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles
Citing Articles via Google Scholar
Google Scholar

Articles by Papadogeorgakis, H

Articles by Smith, J S
Search for Related Content
PubMed

PubMed Citation
Social Bookmarking

What’s this?


Original research articles


H Papadogeorgakis MD PhD * ,
C Caroni PhD ,
A Katsambas MD * ,
J M Pimenta PhD ,
C Avdeliodi MD **,
T Kotrotsou MD ,
E Frangoulis MD PhD *  and
J S Smith PhD MPH  


* Department of Microbiology;
Department of Dermatology, ‘A. Sygros’ Dermatology Hospital, University of Athens;
Department of Mathematics, National Technical University of Athens, Athens, Greece;
Worldwide Epidemiology, GlaxoSmithKline, Greenford, UK;
** ‘H. Venizelos’ Maternity Hospital;
‘Agia Sophia’ University Children’s Hospital, Athens, Greece;
Department of Epidemiology, University of North Carolina, NC, USA

Correspondence to: Dr Jennifer S Smith, Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA Email: JenniferS{at}unc.edu

The aim was to study the type-specific seroprevalence of Herpessimplex virus (HSV)-1 and HSV-2 infections and the associatedrisk factors in children, adolescents and adults in Greece.A total of 1867 serum samples from children, adolescents andadults of both genders aged from 0 to 60 years were collectedfrom three large hospital-referral centres in Athens. All serawere tested for type-specific antibodies to HSV-1 and HSV-2using HerpeSelect IgG ELISA tests (Focus Diagnostics Cypress,Cal, USA). Overall age-adjusted seroprevalence of HSV-1 andHSV-2 was 72.0% and 10.2%, respectively. HSV-1 seropositivitywas low in children up to nine years of age, increased sharplyin adolescence, and was higher in females than males in eachgroup surveyed. HSV-2 seropositivity was low (0.8%) below 20years of age and increased to a maximum prevalence of 18.7%in men and 22.7% in women. Multivariate risk factor analysesindicated that HSV-1 seropositivity was associated with socioeconomicindicators (e.g. lower educational level, residency outsidegreater Athens), whereas HSV-2 was associated with sexual behaviouralfactors (e.g. being divorced, greater number of lifetime sexualpartners). HSV-2 risk factor profiles were similar in womenand in men. This first large seroprevalence study in Greeceshowed a high age-standardized HSV-1 seropositivity after adolescenceand a relatively low age-standardized HSV-2 seroprevalence frombirth to 60 years of age. Dual seropositivity to HSV-1 and HSV-2was low (0.6%) in females under 20 years of age, suggestingthat the potential use of an HSV-2 prophylactic vaccine in adolescentscould reduce the spread of HSV-2 infection.

Key Words: Herpes simplex virus • seroprevalence • risk factors • Greece

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?